Silicon Valley Capital Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Silicon Valley Capital Partners's BSX Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Boston Scientific (BSX) stake by 0.46% in Q1 2026, buying an estimated $2.08K and bringing the position to 5,625 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #75.
Silicon Valley Capital Partners first reported a position in BSX in Q3 2018 and has held it in 28 quarters since. The position peaked at $601K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Silicon Valley Capital Partners held 5,625 shares of Boston Scientific worth $353K as of Q1 2026.
- Silicon Valley Capital Partners bought 26 Boston Scientific shares in Q1 2026, an estimated $2.08K.
- Boston Scientific made up 0.03% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #75 holding.
- Silicon Valley Capital Partners first reported a position in Boston Scientific in Q3 2018 and has held it in 28 quarters since.
- Silicon Valley Capital Partners's Boston Scientific position peaked at $601K in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.